Validation parameters cannot be obtained without using pure substance

Journal of Pharmaceutical and Biomedical Analysis

Volumn 56, Issue 2, 2011, Pages 462-463

  Van der Elst, Kim C M ^a   Uges, Donald R A ^a   Alffenaar, Jan Willem C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

14 hydroxyclarithromycin; LC MS MS; Method validation; Pure substance; Sensitivity

Indexed keywords

14 HYDROXYCLARITHROMYCIN; CLARITHROMYCIN; RIFAMPICIN;

DRUG DETERMINATION; HUMAN; LETTER; LUNG ALVEOLUS CELL; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; VALIDATION PROCESS;

ANIMALS; ANTI-BACTERIAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CLARITHROMYCIN; HORSE DISEASES; PULMONARY ALVEOLI; RESPIRATORY TRACT INFECTIONS; RIFAMPIN;

EID: 79960048017     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.04.021     Document Type: Letter

References (5)

1. Oswald S., Peters J., Venner A., Siegmund W. LC-MS/MS method for the simultaneous determination of clarithromycin, rifampicin and their main metabolites in horse plasma, epithelial lining fluid and broncho-alveolar cells. J. Pharm. Biomed. Anal. 2011, 55:194-201.
2. de Velde F., Alffenaar J.W., Wessels A.M., Greijdanus B., Uges D.R. Simultaneous determination of clarithromycin, rifampicin and their main metabolites in human plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2009, 877:1771-1777.
3. Womble A.Y., Giguère S., Lee E.A., Vickroy T.W. Pharmacokinetics of clarithromycin and concentrations in body fluids and bronchoalveolar cells of foals. Am. J. Vet. Res. 2006, 67:1681-1686.
4. Alffenaar J.W., Nienhuis W.A., de Velde F., Zuur A.T., Wessels A.M., Almeida D., Grosset J., Adjei O., Uges D.R., van der Werf T.S. Pharmacokinetics of rifampin and clarithromycin in patients treated for mycobacterium ulcerans infection. Antimicrob. Agents. Chemother. 2010, 54:3878-3883.
5. Rozet E., Marini R.D., Ziemons E., Boulanger B., Hubert Ph. Advances in validation risk and uncertainty assessment of bioanalytical methods. J. Pharm. Biomed. 2011, 10.1016/j.jpba.2010.12.018.